Effectiveness of affect regulation treatment on the treatment outcomes of patients with irritable bowel syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240602061987N1

Enrollment

Registered

2025-01-20

Start date

2025-02-19

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome

Interventions

Intervention 1: The first intervention group: Weekly two-hour sessions of affect regulation therapy are conducted according to the protocol of affect regulation therapy (ART) based on the study of Ber

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Diagnosing irritable bowel syndrome by a gastroenterologist based on the Rome IV criteria Age between 18 and 55 years Literacy level above middle school

Exclusion criteria

Exclusion criteria: Suffering from manic states or having psychotic symptoms based on SCID (SCID-5-CV) Suffering from severe depression that prevents effective processing of educational concepts according to SCID Having a drug addiction based on the SCID The severity of the disease and symptoms related to irritable bowel syndrome should be such that the person is unable to participate in the sessions (such as bleeding or severe pain), which is measured through a clinical interview. The existence of high and medium risk level of suicide which is measured through interview.

Design outcomes

Primary

Measure	Time frame
Severity of gastrointestinal symptoms. Timepoint: beginning and end and three months after the end of treatment. Method of measurement: Gastrointestinal Syndrome Rating Scale of Revicki (1998).;Visceral Sensitivity. Timepoint: beginning and end and three months after the end of treatment. Method of measurement: Visceral Sensitivity Index of Labus et al.;Executive Function. Timepoint: beginning and end and three months after the end of treatment. Method of measurement: Behavior Rating Inventory of Executive Function (BRIEF).;Emotional Processing. Timepoint: beginning and end and three months after the end of treatment. Method of measurement: Emotional Processing Scale (EPS) Baker et al.;Psychological disturbances. Timepoint: beginning and end and three months after the end of treatment. Method of measurement: Depression Anxiety Stress Scales-Short Form (DASS-21).	—

Measure

Time frame

Severity of gastrointestinal symptoms. Timepoint: beginning and end and three months after the end of treatment. Method of measurement: Gastrointestinal Syndrome Rating Scale of Revicki (1998).;Visceral Sensitivity. Timepoint: beginning and end and three months after the end of treatment. Method of measurement: Visceral Sensitivity Index of Labus et al.;Executive Function. Timepoint: beginning and end and three months after the end of treatment. Method of measurement: Behavior Rating Inventory of Executive Function (BRIEF).;Emotional Processing. Timepoint: beginning and end and three months after the end of treatment. Method of measurement: Emotional Processing Scale (EPS) Baker et al.;Psychological disturbances. Timepoint: beginning and end and three months after the end of treatment. Method of measurement: Depression Anxiety Stress Scales-Short Form (DASS-21).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamane Soltanabadi

Iran University of Medical Sciences

samane.soltanabadi@gmail.com+98 938 470 1029

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026